Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
243.80
-17.9 (-6.84%)
BSENSE

Feb 06

BSE+NSE Vol: 2.26 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
425.75
436.25
366.67
376.80
272.07
300.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
425.75
436.25
366.67
376.80
272.07
300.38
Raw Material Cost
201.93
222.34
193.04
226.49
136.52
120.77
Purchase of Finished goods
11.18
13.33
13.77
14.50
7.95
19.33
(Increase) / Decrease In Stocks
-2.97
-3.47
21.50
-17.71
-7.14
2.12
Employee Cost
77.81
66.78
60.30
56.86
49.50
53.44
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
-0.02
0.00
0.00
-0.02
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
92.87
85.41
69.07
74.14
65.46
73.43
Total Expenditure (Excl Depreciation)
380.83
384.40
357.66
354.28
252.29
269.07
Operating Profit (PBDIT) excl Other Income
44.92
51.85
9.01
22.52
19.78
31.31
Other Income
3.42
2.06
2.98
0.86
1.19
0.46
Operating Profit (PBDIT)
48.34
53.91
11.99
23.38
20.97
31.77
Interest
27.91
21.72
13.87
15.82
17.29
22.45
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
20.43
32.19
-1.88
7.56
3.68
9.32
Depreciation
9.93
9.75
9.32
8.45
7.16
7.32
Profit Before Tax
10.49
22.44
-11.20
-0.90
-3.48
2.00
Tax
0.22
0.11
0.20
0.17
0.17
-0.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10.28
22.32
-11.41
-1.07
-3.65
2.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10.28
22.32
-11.41
-1.07
-3.65
2.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10.28
22.32
-11.41
-1.07
-3.65
2.08
Equity Capital
32.77
32.75
32.71
32.66
25.02
23.72
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
0.35
3.13
-1.0
0.12
2.36
-0.9
Operating Profit Margin (Excl OI)
10.55%
11.89%
2.46%
5.98%
7.27%
10.42%
Gross Profit Margin
4.8%
7.38%
-0.51%
2.01%
1.35%
3.1%
PAT Margin
2.41%
5.12%
-3.11%
-0.28%
-1.34%
0.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.08% vs -2.41% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 332.20% vs -53.94% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 71.22% vs -13.37% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -21.46% vs 28.50% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Wanbury With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
425.75
0
425.75
Other Operating Income
0.00
0.00
0.00
Total Operating income
425.75
0
425.75
Raw Material Cost
201.93
0
201.93
Purchase of Finished goods
11.18
0
11.18
(Increase) / Decrease In Stocks
-2.97
0
-2.97
Employee Cost
77.81
0
77.81
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
92.87
0.00
92.87
Total Expenditure (Excl Depreciation)
380.83
0
380.83
Operating Profit (PBDIT) excl Other Income
44.92
0.00
44.92
Other Income
3.42
0
3.42
Operating Profit (PBDIT)
48.34
0
48.34
Interest
27.91
0
27.91
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
20.43
0
20.43
Depreciation
9.93
0
9.93
Profit Before Tax
10.49
0
10.49
Tax
0.22
0
0.22
Provisions and contingencies
0.00
0
0.00
Profit After Tax
10.28
0
10.28
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
10.28
0
10.28
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.28
0
10.28
Equity Capital
32.77
0
32.77
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
4.80%
0.00%
0.00
4.80%
PAT Margin
2.41%
0.00%
0.00
2.41%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 485.69 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.08% vs -2.41% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 44.43 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 332.20% vs -53.94% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 76.91 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 71.22% vs -13.37% in Dec 2024

Nine Monthly - Interest
Interest 21.92 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -21.46% vs 28.50% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.84%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024